moxonidine has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K; Bielenberg, GW; Ehmke, H; Gross, ML; Koch, A; Mall, G; Oberhauser, V; Orth, SR; Ritz, E; Rump, LC; Simonaviciene, A; VAN Kats, JP; Wessels, S | 1 |
1 other study(ies) available for moxonidine and transforming growth factor beta
| Article | Year |
|---|---|
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; Imidazoles; Immunohistochemistry; In Situ Hybridization; Kidney; Male; Nephrectomy; Neural Inhibition; Norepinephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Sympathetic Nervous System; Transforming Growth Factor beta | 2000 |